DDInter61 DDInter1180
Ambenonium is a cholinesterase inhibitor. It is used in the management of myasthenia gravis.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Ambenonium {u} (Compound) binds {v} (Gene) BCHE
Ambenonium {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Trospium
Ambenonium {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Tetracosactide
Ambenonium (Compound) binds BCHE (Gene)
Ambenonium may cause a moderate interaction that could exacerbate diseases when taken with Trospium
Ambenonium may cause a moderate interaction that could exacerbate diseases when taken with Tetracosactide